Key result
Labile hypertension carries clinical relevance but lacks evidence to guide therapeutic decisions.
Why the study?
Management of the labile component of blood pressure elevation is a common clinical problem with limited information to guide therapeutic decisions.
There is a lack of information to guide therapeutic decisions for labile hypertension, highlighting a need for future research.
Answers are grounded in this paper and cite their sources.
Labile hypertension lacks evidence-based therapeutic guidance; leaves open optimal management pending dedicated prospective trials.
J Clin Hypertens (Greenwich). 2009;11:491-497. (c)2009 Wiley Periodicals, Inc.Although the management of the labile component of blood pressure elevation is a problem often encountered by clinicians, there is a paucity of information available to guide therapeutic decisions. This review discusses the clinical relevance of blood pressure lability, the limitations of current knowledge, and possible directions for future research and clinical management.
No takes yet. Share an insight, caveat, or question.
Samuel J. Mann (2009) conducted a review in Labile hypertension. Management of labile hypertension was evaluated. A review of labile hypertension highlights the clinical relevance of blood pressure lability and the current lack of evidence to guide therapeutic decisions.
Synapse has enriched 10 related papers. Consider them for comparative context: